Aurinia Pharmaceuticals
AUPH
AUPH
198 hedge funds and large institutions have $483M invested in Aurinia Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 64 increasing their positions, 50 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
198
Holders Change
+14
Holders Change %
+7.61%
% of All Funds
3.12%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
33
Increased
64
Reduced
50
Closed
18
Calls
$22.5M
Puts
$20.8M
Net Calls
+$1.67M
Net Calls Change
-$6.98M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$7.3M |
| 2 |
Two Sigma Investments
New York
|
+$6.24M |
| 3 |
TAL
TIG Advisors LLC
New York
|
+$5.43M |
| 4 |
JGC
J. Goldman & Co
New York
|
+$5.35M |
| 5 |
AC
Armistice Capital
New York
|
+$5.03M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$20.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$13.5M |
| 3 |
N
Natixis
Paris,
France
|
-$9.32M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.91M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$4.39M |
